MX9503363A - Phtalmide n-(2,6-dioxo-3-piperidyl)(generic talydomide as treatment of the worn syndrome associated with the infection by hiv-1.
- Google Patents
Phtalmide n-(2,6-dioxo-3-piperidyl)(generic talydomide as treatment of the worn syndrome associated with the infection by hiv-1.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nac De La Nutricion Salva, ZubiranfiledCriticalInst Nac De La Nutricion Salva
Priority to MXPA/A/1995/003363ApriorityCriticalpatent/MXPA95003363A/en
Priority claimed from MXPA/A/1995/003363Aexternal-prioritypatent/MXPA95003363A/en
Publication of MX9503363ApublicationCriticalpatent/MX9503363A/en
Publication of MXPA95003363ApublicationCriticalpatent/MXPA95003363A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention refers to the use of 2-(2,6-dioxo-3-piperidinyl)-1H-isoindol-1-1,3 (2H)-dione; N-(2,6-dioxo-3-piperidyl)phtalimide; a-phtalimidoglutarimide (generic Talidomide) in the treatment of worn syndrome (WS) in patients in the final stage, affected by HIV-1 (AIDS) or any disease (example: cancer) wherein said worn syndrome is manifested as complication of the same suffering and its possible therapeutic association with other useful chemical entities in these sufferings.
MXPA/A/1995/003363A1995-08-04N- (2,6-dioxo-3-piperidil) ftalimide (generic talidomide as treatment of the wear syndrome associated with infection by vi
MXPA95003363A
(en)
THERAPEUTICALLY MEANS CONTAINING OXYGEN ANION-RADICALS AND / OR PRODUCTS OF THEIR SUBSEQUENTAL TURNING AND DIVISION AND THEIR APPLICATION FOR THE TREATMENT OF PARKINSON'S DISEASE